跳至主要内容
临床试验/IRCT20201119049445N2
IRCT20201119049445N2招募中1 期

The effect of adding N-acetylcysteine ??to the usual treatments of schizophrenia on the positive, negative and cognitive symptoms of patients with schizophrenia admitted

Esfahan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 65 years(—)
性别
All

入选标准

  • Patients with schizophrenia between the ages of 19 and 65 who have undergone the acute phase (the onset of the acute phase is assessed by a psychiatrist and the project resident)
  • Diagnosis of schizophrenia based on DSM 5 criteria by a psychiatrist
  • Have at least five classes of education

排除标准

  • Pregnancy and lactation
  • Substance abuse
  • Severe physical illness
  • Contraindications to the use of N-acetylcysteine
  • Existence of intellectual disability
  • Receive ECT 6 months before or during the study
  • Patients treated with nitroglycerin
  • Patients treated with insulin
  • Patients treated with chloroquine
  • Patients treated with more than 200 mg of selenium
  • Patients treated with anticoagulants except aspirin and NSAIDs

研究者

相似试验